Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of pleuromulin cas 125-65-5 in China. Welcome to wholesale bulk high quality pleuromulin cas 125-65-5 for sale here from our factory. Good service and reasonable price are available.
Pleuromulin is a unique tricyclic diterpene antibiotic that was initially isolated from higher fungi (such as Pleurotus mutilus, now known as Clitopilus passeckerianus) in the 1950s. Its antibacterial mechanism is highly specific, by binding with high affinity to the peptidyl transferase center of the 50S subunit of bacterial ribosomes (sharing some overlapping sites with lincomycin and truncated cephalosporin), directly inhibiting the formation of peptide bonds during protein synthesis, but having little effect on the mitochondrial ribosomes of eukaryotes, with high selectivity.

|
Chemical Formula |
C22H34O5 |
|
Exact Mass |
378 |
|
Molecular Weight |
379 |
|
m/z |
378 (100.0%), 379 (23.8%), 380 (2.7%), 380 (1.0%) |
|
Elemental Analysis |
C, 69.81; H, 9.05; O, 21.13 |
The development of this compound and its series of semi-synthetic derivatives (such as lefamulin) is mainly aimed at the increasingly severe problem of antibiotic resistance in Gram-positive bacteria, especially showing strong activity against multi-drug-resistant Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Enterococcus faecalis, and can effectively penetrate biofilms. Due to its novel target and the difficulty of cross-resistance with other antibiotics, it is regarded as an important reserve drug for combating antibiotic-resistant infections in veterinary medicine and human medicine (especially for local topical treatment such as bacterial skin infections), and its complex structure and synthetic challenges continue to attract in-depth research by organic synthetic chemists.

Pleuromulin is a class of potent antibacterial agents first isolated from the edible mushroom Clitophilus scyphoides in 1951, with a unique mechanism of inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit, thus avoiding cross-resistance with other major antibiotic classes. Its applications are mainly divided into veterinary medicine and human medicine, with semisynthetic derivatives playing a key role in both fields. In veterinary medicine, it is widely used to treat bacterial infections in food-producing animals, especially pigs and poultry.
Derivatives like tiamulin and valnemulin are effective against swine dysentery, porcine proliferative enteropathy, and enzootic pneumonia, as well as Mycoplasma infections in poultry and epizootic rabbit enteropathy, with specific doses adjusted for different animals and administration routes including feed, drinking water, and intramuscular injection. In human medicine, the development of derivatives has expanded its application: retapamulin is used topically for skin infections, while lefamulin, approved by the FDA in 2019, is the first systemic pleuromutilin for treating community-acquired bacterial pneumonia and acute bacterial skin infections. Notably, Pleuromulin has low spontaneous mutation frequency and slow resistance development, making it valuable in combating drug-resistant pathogens, though its use requires prudent monitoring to prevent resistance emergence.

Pleurotus truncatus and its derivatives can inhibit the synthesis of bacterial proteins at the ribosome level, and have a unique effect on many Gram-positive bacteria and mycoplasma infections.
In 1951, Kavanagh et al. First reported the separation and characterization of crystalline antibacterial substances of truncated pleuridin.
In 1974, Sandoz Institute found a derivative of tylosin, which is 10-100 times higher than that of truncated Pleurotus. This compound replaces the C-14 hydroxyl of truncated Pleurotus with (diethylaminoethyl) sulfhydryl. In addition to the antibacterial activity of truncated Pleurotus, it shows strong antibacterial activity against Shigella, Klebsiella and Escherichia coli, and is one of the commonly used veterinary antibiotics in the veterinary drug market at present, It mainly treats gastrointestinal and respiratory diseases of livestock and poultry in the form of feed additives, veterinary drugs and drinking water.
In 1976, knausederf et al. Carried out a preliminary study on the fermentation conditions, chemical structure and biosynthetic pathway of truncated pleurotin producing bacteria. Valnemulin, which was subsequently launched, is also used as an animal specific antibiotic to treat respiratory diseases in pigs and chickens and epidemic enteritis in rabbits. Valnemulin is a new generation of semi synthetic antibiotics of pleuromulin. It belongs to diterpenes and belongs to the same class of drugs as tylosin. It is a special antibiotic for animals. It is mainly used to prevent and treat Mycoplasma disease and gram-positive bacterial infection in pigs, cattle, sheep and poultry. It is mainly concentrated in the lungs and is an ideal drug for the treatment of lung diseases caused by various moldy bodies.
In 2007, nearly 50 years after the discovery of truncated pleurotin, the first truncated pleurotin antibiotic retapamulin was approved for clinical use, and it is only used as a local drug to treat pustulosis caused by Staphylococcus aureus and Streptococcus pyogenes in adults and children over 9 months old.
In 2019, after nearly 60 years of development, lefamulin (bc-3781), the latest truncated pleurotin drug, completed phase 3 clinical trials in 2018 and submitted a new drug application to the FDA in February 2019. It is expected to become the first human truncated pleurotin antibiotic that can be used systemic for the treatment of community-acquired bacterial pneumonia (intravenous or oral administration).

Pleuromulin is a broad-spectrum diterpene antibiotic produced by Pleurotus ostreatus.
1. It can inhibit the synthesis of bacterial protein, so as to achieve the effect of inhibiting bacterial growth. Its mode of action is different from other types of antibiotics.
2. In terms of mechanism of action. Truncated Pleurotus antibiotics mainly act on the ribosome level of bacterial cells. It blocks the synthesis of bacterial proteins by inhibiting the activity of peptidyl transferase, so as to achieve a broad-spectrum antibacterial effect.
The truncated Pleurotus ostreatus drug is composed of three rings, forming the main skeleton, and its basic structure is an eight membered ring; The carbonyl group on the five membered ring and the hydroxyl group on C-11 are necessary groups for activity. Most of the studies abroad are chemical modification of C-14 to greatly improve its antibacterial activity and bioavailability. Because the C-14 of the truncated pleurotin drug contains free hydroxyl, it has no activity; By modifying the structure of C-14 into, derivatives with enhanced antibacterial activity against bacteria and mycoplasma can be obtained.
In addition, the antibacterial activity of compounds with neutral or acidic groups connected by C-14 side chains is very low, and the activity of connecting two basic side chains is also very low; However, the activity of thioether side chain derivatives connected to the basic center has been decisively improved. For example, tamoxin fumarate is a drug that contains thioether side chains. However, if the sulfur atom in the Thioether Group is replaced by the oxygen atom, the activity of the truncated pleurotin drug will be sharply reduced. If other basic substituents, such as guanidine or primary amine, are added to the side chain at the C-14 position, the activity level of thioether derivatives cannot be reached, and it is easy to hydrolyze and inactivate in vivo. Therefore, acylation modification of the C-14 position of the truncated pleurotin compound can significantly reduce the minimum inhibitory concentration and improve the antibacterial activity.

1. Molecular structural characteristics
The molecular structure of Pleuromulin consists of four circular structures, as shown in the figure. Among them, the first ring is a benzo ring, the second ring is an oxygen heterocyclic ring, the third ring is a nitrile heterocyclic ring, and the fourth ring is a pyrrole ring. They are interconnected through C-C and C-N single bonds, forming complex molecular structures. This category of polycyclic compounds is commonly referred to as polycyclic ketones or polycyclic lactones.

2. Molecular structure analysis
The molecular structure of it can be determined through various analytical techniques, including spectroscopy, mass spectrometry, and X-ray crystallography.
(1) Spectroscopic analysis
Ultraviolet spectroscopy can provide information on the electronic structure of product. It exhibits two distinct absorption peaks in the ultraviolet region, located at 246 nm and 279 nm, respectively. These peaks can be attributed to their π - π * transitions and n - π * transitions. Near infrared spectroscopy can provide information about the molecular vibrational modes of product. The near-infrared spectroscopy shows the vibrational bands of various functional groups, such as carbonyl, hydroxyl, amino, and oxygen groups.
Nuclear magnetic resonance (NMR) technology can provide molecular structure information of product. Usually, ^ 1H NMR spectroscopy and ^ 13C NMR spectroscopy are used to determine its structure. In the ^ 1H NMR spectrum, it displays multiple chemical shift peaks, and the differences between these peaks can be used to determine the positions of different protons in the molecule. For example, it shows three peaks of methylene protons, with a single peak at 0.8 ppm caused by the first methylene proton, and a double peak at 1.2 ppm caused by the second and third methylene protons.
(2) Mass spectrometry analysis
Mass spectrometry is a very important tool that can provide molecular weight and structural information of molecules. In mass spectrometers, it is typically analyzed using high-resolution liquid chromatography-mass spectrometry (LC-MS). Electro spray ionization (ESI) or atmospheric pressure chemical ionization (APCI) are commonly used ionization technologies. In the mass spectrum, it shows the molecular ion peak [M+H] ^+at m/z 372, which conforms to its molecular formula.
(3) X-ray crystallographic analysis
X-ray crystallography is a technique used to determine crystal structure by projecting crystals into a beam of radiation, collecting scattering data, and using computational methods to analyze molecular structure. When using this technology, Pleuromulin needs to be crystallized and formed into a single crystal. Then, the crystal structure is determined by measuring the scattering mode of the crystal under an X-ray beam. Ultimately, X-ray crystallography technology can provide detailed information on molecular flow direction, atomic distance, and angle.

Pleuroutilin, a diterpene antibiotic derived from the fungus Pleurotus utilis, serves as a vital precursor for the semi-synthetic development of truncated Pleurotus drugs. This class of antibiotics, particularly the Pleurotus truncatus antibiotics, represents a promising advancement in the field of antimicrobial therapy.
These novel antibiotics exhibit remarkable antibacterial properties, capable of effectively combating a broad spectrum of pathogens. Notably, they demonstrate potent activity against Gram-positive bacteria, mycoplasma, and even some strains of Gram-negative bacteria. This broad-spectrum activity is highly valuable in clinical settings where infections caused by multiple bacterial species can be challenging to treat.
Moreover, the Pleurotus truncatus antibiotics stand out for their resistance to drug resistance. As bacterial strains increasingly develop resistance to conventional antibiotics, the discovery of new agents that can overcome this resistance is crucial for maintaining effective treatments. The ability of these antibiotics to retain their efficacy against resistant strains underscores their potential as valuable additions to the antimicrobial arsenal.
The semi-synthetic derivatives of Pleuroutilin, based on its unique chemical structure, offer even further opportunities for optimization and enhancement of antibacterial activity. Researchers can modify the precursor molecule to create new compounds with improved pharmacological profiles, such as increased potency, reduced toxicity, or enhanced bioavailability.
In summary, Pleuroutilin and its semi-synthetic derivatives represent a promising new class of antibiotics with broad-spectrum activity, resistance to drug resistance, and the potential for further optimization. These attributes make them attractive candidates for the development of new treatments for bacterial infections, particularly those caused by multi-drug resistant strains.
What are the side effects of this compound?
Gastrointestinal reactions: Symptoms of gastrointestinal discomfort such as nausea, vomiting, and diarrhea may occur. These symptoms are usually mild and gradually improve after discontinuation of medication.
Allergic reactions: Some individuals may experience allergic reactions to the substance, manifested as rash, itching, urticaria, and other symptoms. Severe allergic reactions may include difficulty breathing, laryngeal edema, shock, etc., requiring immediate medical attention.
Neurological response: In some cases, it may cause neurological discomfort symptoms such as dizziness, headache, and drowsiness. These symptoms may affect the patient's daily life and work.
Liver and kidney damage: Long term or excessive use of this substance may cause damage to liver and kidney function. Patients with liver and kidney dysfunction need to be particularly careful when using it and adjust the dosage under the guidance of a doctor.
Other side effects: May include fever, chills, and pain at the injection site. A small number of patients may experience blood system abnormalities such as leukopenia and thrombocytopenia.
FAQ
What is pleuromutilin?
+
-
Pleuromutilins are antibiotics that selectively inhibit bacterial translation and are semisynthetic derivatives of the naturally occurring tricyclic diterpenoid pleuromutilin, which received its name from the pleuromutilin-producing fungus Pleurotus mutilus.
What are pleuromutilin derivatives?
+
-
Pleuromutilin derivatives refer to antibiotic compounds derived from the fungal metabolite pleuromutilin, which act by inhibiting protein synthesis and have applications in treating infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).s steel is not similar to mineral materials,after use can release some substances to promote human absorption.
Hot Tags: pleuromulin cas 125-65-5, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Ethacridine Lactate Monohydrate CAS 6402 23 9, Paliperidone powder, 4 Methylpropiophenone, Methylergonovine Powder CAS 113 42 8, eriodictyol powder, Iodomethane-d3


